Costs and Effectiveness of Genomic Testing in the Management of Colorectal Cancer
March 15th 2015Numerous genomic tests are available for use in colorectal cancer, with a widely variable evidence base for their effectiveness and cost-effectiveness. In this review, we highlight many of these tests, with a focus on their proposed role, the evidence base to support that role, and the associated costs and risks.